Supplementary Figure S3 from Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer | Synapse
March 1, 2024Open Access
Supplementary Figure S3 from Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Figure S3. Patient-level concentration profile of bintrafusp alfa at Day 1 postdose.